Physician profile
Titus C Abraham
NPI 1598764540
$6,148.37
in general payments reported to CMS, 2019-2025
47 companies · $1,407 in 2025
The $1,407 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $50.05 · 2022: $21.32 · 2023: $1,459 · 2024: $2,912 · 2025: $1,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,890 · Travel and Lodging: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,889.81 |
| Travel and Lodging | $888.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $1,541.39 | 2023-2024 | |
| Abbvie INC. | $791.27 | 2023-2025 | Vraylar, Ubrelvy, Linzess |
| Pfizer INC. | $675.26 | 2019-2025 | |
| Novo Nordisk INC | $573.90 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $287.56 | 2023-2025 | Veozah |
| Glaxosmithkline, LLC. | $247.33 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $245.25 | 2023-2025 | Mounjaro, Zepbound, Kisunla |
| Amgen INC. | $206.49 | 2019-2025 | Evenity, Prolia, Krystexxa |
| Exact Sciences Corporation | $155.53 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $127.84 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.92 | 2023-2025 | Jardiance |
| Sumitomo Pharma America, INC. | $94.11 | 2023-2025 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $84.40 | 2023-2025 | Airsupra, Farxiga |
| Abbott Laboratories | $82.33 | 2020-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $63.73 | 2023-2024 | Xarelto |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $63.63 | 2019-2024 | Omnipod |
| Seqirus USA INC | $62.32 | 2019-2025 | Flucelvax, Fluad |
| Hologic Sales and Service, LLC | $46.28 | 2024 | Aptima |
| Lundbeck LLC | $45.29 | 2024-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $43.08 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $41.77 | 2023 | Jynarque, Rexulti |
| Idorsia Pharmaceuticals US INC | $41.42 | 2023 | Quviviq |
| Becton, Dickinson and Company | $38.80 | 2024-2025 | Bd Max System, Bd Max Instrument |
| Xeris Pharmaceuticals, INC. | $35.56 | 2025 | Gvoke Hypopen |
| Amarin Pharma, INC. | $33.96 | 2019 | |
| Medtronic Vascular, INC. | $32.75 | 2020 | |
| Abiomed | $29.81 | 2024 | Impella |
| Sanofi-Aventis U.S. LLC | $28.36 | 2025 | |
| Tactile Systems Technology INC | $23.86 | 2025 | Flexitouch Plus, Nimbl |
| Array Biopharma INC | $22.79 | 2025 | Braftovi |
| Vertical Pharmaceuticals, LLC | $22.16 | 2024 | Relexxii |
| Cequr Corporation | $22.14 | 2025 | Cequr Simplicity |
| Medtronic Minimed, INC. | $21.58 | 2019 | |
| Sanofi Pasteur INC. | $21.55 | 2023 | |
| Lifescan, INC. | $21.32 | 2022 | |
| Gilead Sciences, INC. | $20.88 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.85 | 2024 | |
| Tms Neurohealth Centers INC. | $18.57 | 2025 | Tms Neurohealth Centers INC. |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.82 | 2024 | Xifaxan |
| Baxter Healthcare | $16.40 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Biotronik INC. | $14.91 | 2019 | |
| Medtronic, INC. | $14.84 | 2024 | Closurefast |
| Genentech USA, INC. | $14.77 | 2025 | Phesgo |
| Inspire Medical Systems, INC. | $13.99 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $11.60 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Titus Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.